Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis

NCT02466074 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Inadequate recruitment; termination of funding

Conditions

Multiple Sclerosis

Interventions

DRUG: Acetazolamide
DRUG: Placebo

Sponsor

The University of Texas Health Science Center, Houston